Cantourage Aktie

Cantourage für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A3DSV0 / ISIN: DE000A3DSV01

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>
09.12.2025 08:00:03

EQS-News: Cantourage appoints new member to its Management Board: Monique Jaqqam becomes Chief Financial Officer – Supervisory Board prolongs CEO Philip Schetter's mandate by five years

EQS-News: Cantourage Group SE / Key word(s): Personnel
Cantourage appoints new member to its Management Board: Monique Jaqqam becomes Chief Financial Officer – Supervisory Board prolongs CEO Philip Schetter's mandate by five years

09.12.2025 / 08:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


Not for release, publication or distribution, directly or indirectly, in or intothe United States of America, Australia, Canada or Japan or any otherjurisdiction in which such release, publication or distribution would be unlawful. The important notes at the end of this announcement need to be observed.

 

Berlin, December 9, 2025 – The Supervisory Board of Cantourage Group SE has appointed Mrs. Monique Jaqqam to the Management Board as Chief Financial Officer (CFO) with effect from January 1, 2026. In her new role, Mrs. Jaqqam will be responsible for finance, HR, legal, and IT. With her appointment, the Management Board of Cantourage Group SE expands to two members. Mrs. Jaqqam's mandate is for five years.

In addition, the Supervisory Board has extended CEO Philip Schetter's mandate for another five years, sending a clear signal of continuity and stability in corporate management.

“We are convinced that Mrs. Jaqqam's proven financial expertise is an ideal addition to our Management Board team,” says Christian Schreyer, Chairman of the Supervisory Board of Cantourage Group SE. “Together with Mr. Philip Schetter (CEO), she will continue to drive the Group's profitable growth.”

“I look forward to working with Monique Jaqqam. With her deep financial expertise, she strengthens our organization in precisely those areas that are essential for our further growth. Together, we will consistently shape the next phase of Cantourage's development,” says Philip Schetter, CEO of Cantourage Group SE.

“In a dynamic growth environment, a resilient financial architecture is crucial. My goal is to consistently strengthen these structures and thus support the further growth of the Cantourage Group in a sustainable and transparent manner,” said Monique Jaqqam, commenting on her appointment as CFO.

About Monique Jaqqam

Monique Jaqqam holds a degree in business administration and has been Group CFO of the Future Group in Berlin since August 2023. She has more than 20 years of international management experience in finance, private equity, real estate, and hospitality. Previously, she was Group CFO at Basecamp Student and held senior finance positions at Kempinski Hotels. Her focus is on financial transformation, building modern financial structures, and supporting complex transactions.

Monique Jaqqam to take over as CFO of Cantourage Group SE on January 1, 2026

Monique Jaqqam to take over as CFO of Cantourage Group SE on January 1, 2026

About Cantourage
Cantourage is a leading European producer and distributor of cannabis flowers and cannabis-based medicinal preparations and drugs. The Berlin-based company was founded in 2019 by industry pioneers Norman Ruchholtz, Dr. Florian Holzapfel and Patrick Hoffmann. With an experienced management team and its “Fast Track Access” platform, Cantourage enables producers from around the world to become part of the growing European medical cannabis market faster, easier and more cost-effectively by processing and distributing their cannabis raw materials and extracts. In this context, Cantourage ensures compliance with the highest European pharmaceutical quality standards at all times. The company offers pharmaceutical-grade products in all relevant market segments: dried flower, extracts, dronabinol and cannabidiol. Cantourage was listed on the Frankfurt Stock Exchange on 11 November 2022 and is listed under ISIN DE000A3DSV01

Further information: www.cantourage.com

Investor Relations contact at Cantourage
Manuel Taverne
taverne@cantourage.com

 

This announcement does not constitute a public offer or an advertisement for a public offer to sell securities, in particular not within the meaning of Regulation (EU) 2017/1129 (Prospectus Regulation).

 



09.12.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Cantourage Group SE
Feurigstraße 54
10827 Berlin
Germany
E-mail: info@cantourage.com
Internet: https://www.cantourage.com/
ISIN: DE000A3DSV01
WKN: A3DSV0
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Scale), Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2242076

 
End of News EQS News Service

2242076  09.12.2025 CET/CEST

Analysen zu Cantouragemehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Cantourage 2,82 1,08% Cantourage